🇺🇸 FDA
Patent

US 9267154

Targeted integration into the PPP1R12C locus

granted A61PA61P43/00

Quick answer

US patent 9267154 (Targeted integration into the PPP1R12C locus) held by Sangamo Biosciences, Inc. expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P43/00